1016403

Samer Nakhle, M.D. — FEI 3008542139

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 30, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Las Vegas, NV (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance